Clinical Trial Update: Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of eltrombopag in second-line adult primary immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Primacy Immune Thrombocytopenia | Phase 2 | Status: COMPLETED